Rights and permissions
About this article
Cite this article
Monitored isoniazid prophylaxis cost saving for all tuberculin reactors. Pharmacoecon. Outcomes News 147, 10 (1998). https://doi.org/10.1007/BF03277359
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277359